Back to Blog
TECHNOLOGY TRENDS

Technology trends 2024: A glimpse into the future

Varentra Research TeamFebruary 24, 20265 min read

The focus on business transformation, growth, and resiliency using generative AI capabilities is at an inflection point for senior business and technology leaders, the C-suite, and boards of directors.

Leaders face difficult choices regarding models, data, security, user experience, ethical policies, and the overall business value of their AI investments. These decisions are fraught with business risks.

What’s more concerning is that executives are spending valuable resources and time building models disconnected from the processes and business outcomes GenAI is intended to improve. This disconnect is increasing business risks, as models are being developed without the ability to become embedded into a system of action. Very soon, GenAI models will be built directly into a system of action.

Generative AI embedded into business systems of action
The next phase of GenAI moves from isolated models to capabilities embedded directly into the flow of work.

The care we provide helps people heal – and we have peer-reviewed research to prove it. With Varentra, more people get better, significantly improve, and achieve lasting results.

A Consolidated Approach

The creation of strategies today must move from proof of concept to proof of profits through well-defined use cases and embedded capabilities. Competing effectively and efficiently in the future requires leaders to take pragmatic actions now to define their AI platform of the future.

The company deployed embedded predictive intelligence in core processes to identify signals more quickly for employees, thus accelerating time to resolution. This capability was augmented with a powered virtual agent that answers questions using a unified knowledge base of third-party data sources.

Many of these processes have been redesigned, enabling faster responsiveness and the elimination of manual toil and low-value steps. The organization has experienced a cascading value effect as agents and employees can return to work and solve problems faster, leading to exceptional customer experiences.

VR
Written byVarentra Research Team
More articles
Understanding ADMET: The Science Behind Drug Safety
Drug Safety

Understanding ADMET: The Science Behind Drug Safety

A deep dive into Absorption, Distribution, Metabolism, Excretion, and Toxicity — the five pillars that determine whether a drug candidate is safe and effective, and how AI is transforming ADMET profiling.

March 15, 20266 min read
Read More
How AI is Transforming Toxicity Prediction in Drug Discovery
AI & Toxicology

How AI is Transforming Toxicity Prediction in Drug Discovery

Discover how machine learning models predict toxicity earlier in the pipeline, reducing costly late-stage failures and helping researchers design safer molecules from day one.

June 18, 20267 min read
Read More
FOR PHARMA & HEALTHCARE ORGANISATIONS

See TOXmod run on your compounds

We work alongside R&D and data teams at pharmaceutical companies, biotechs, and healthcare institutions — integrating our models into the pipelines and governance frameworks you already run.

Enterprise engagements only — every partnership starts with a technical evaluation against your own targets and data.

Pharma & biotech R&D
Discovery and lead-optimization teams running programs at portfolio scale.
Research institutes & CROs
Computational chemistry groups extending existing in-silico workflows.
Your IP stays yours
Deployed into your environment, under your data governance and access controls.